Hijack This Thread
Posted: Wed Mar 01, 2023 9:51 pm
Hooray for Ms. Shizzle too!!!
That's great news. Congrats!Flatpoint High wrote: ↑Wed Mar 01, 2023 2:22 pm After 10 YeARS being cancer free, I have been released by my Oncologist!!!
https: //media.giphy.com/media/gFi7V9CRBQVW0/giphy.gif
https: //media.giphy.com/media/htHMAjOrrDcUXW7Bn8/giphy.gif
Hurray!
This made me remember how TFB is an amazing nest of truly tough, resilient Bowzers. And not just resilient but kind, smart, funny, introspective and decent. doG knows how many times it dragged me kicking and screaming back to the world.Foggy wrote: ↑Fri Mar 03, 2023 10:25 am Flatpointhigh is an intense, amazing, tough (very tough) lady. She has survived a lot more than cancer, if you've been paying attention. She's a New Yorker, and she's the best of what New York means to me. Do you remember when she was kicked out of her apartment for freaking months during the pandemic? They put her in a hotel, IIRC, but still ...
Growing up in America, New York was the biggest city in the world, with 8 million people.
I know that's a laughably small number today. Tes lived in Shanghai.
But New York is, or was, the pinnacle in this great land of ours. If you can make it there ...
Flatpointhigh can make it there. That lady is awesome.
Jack Daniel’s facility blocked as whiskey vapour blamed for spread of fungus
At least it makes the angels happy.
Ethanol vapour released through porous whiskey barrels during the ageing of bourbon might bring a smile in the heavens – the fumes are known as the “angel’s share” – but it can mean misery for local mortals. A strain of black whiskey fungus feeds on the alcoholic gases, coating neighbourhoods around distilleries with a stubborn mouldy crust.
The spread of the fungus has become such a problem in Lincoln county, Tennessee, that a local court has halted construction of a new barrel warehouse for the world’s biggest-selling brand of American whiskey: Jack Daniel’s.
The move came after the owner of an events venue next to six operating warehouses sued the local zoning office, saying the fungus was out of control and damaging her business.
The fungus, Baudoinia compniacensis, is a familiar pest in the vicinity of barrelhouses which rely on wooden casks. Up to 2% of the volume of the alcohol can evaporate through the barrels each year as the drink matures, sending vapour into the air and encouraging the fungus.
I'm trying to think of anyone claiming to practice "journalism" who does what Stewart does. Jamie Raskins does hold people's feet to the fire. Thank doG he's doing that in hearings and in interviews.Phoenix520 wrote: ↑Sat Mar 04, 2023 3:01 pm That wasn’t so hard, was it? Ask a question, refuse to move on until they actually answer (after they’ve run out of their prepared talking points). Don’t back down.
Stewart should start a J School.
Hospitals and health systems are dealing with a shortage of the inhalation drug albuterol after one of the last manufacturers producing the drug shuttered operations.
Why it matters: Liquid albuterol is a mainstay for treating asthma in kids and was in heavy use for RSV and COVID-19. Health systems have scrambled to get more supplies and figured out workarounds after drugmaker Akorn ceased operations in late February, the Washington Post reported.
Where things stand: Albuterol has been on the national medication shortage list for months, and without action by the Food and Drug Administration, a quick replacement is unlikely to materialize in the near future.
The FDA is reviewing how Akorn's closure will impact the nationwide supply of all the pharmaceuticals they were producing.
The details: Supply chain issues have dogged health care systems throughout the pandemic, including for some of the most commonly used medications.
The FDA could clarify if a new supplier could purchase the technology from Akorn or needs to submit an abbreviated new drug application — a process that could take months.
That makes it sound like it's probably available in that scary for'n country, Restoftheworldia.Wikipedia wrote:Salbutamol was patented in 1966 in Britain and became commercially available in the UK in 1969. It was approved for medical use in the United States in 1982. It is on the World Health Organization's List of Essential Medicines. Salbutamol is available as a generic medication. In 2020, it was the seventh most commonly prescribed medication in the United States, with more than 61 million prescriptions.